Guaifenesin Tablet, Extended Release
Product Images NDC 71179-002

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Guaifenesin (NDC 71179-002). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Vespyr Brands Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (1200 mg Blister Carton (21 (1 x 21) Tablets))

The packaging label for Contac Chest Congestion extended-release tablets, each containing 1200 mg of guaifenesin as an expectorant. The label shows a 21-tablet count bottle by Vespyr Brands LLC. The design emphasizes maximum strength and relief for chest congestion, listing the product's purpose and dosage form clearly on the carton.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.